Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Ecklonia cava is a type of brown seaweed native to the coasts of Korea and Japan, known for its rich content of phlorotannins, a class of polyphenolic compounds. There is some preclinical scientific evidence that supports the potential use of Ecklonia cava extracts in the prevention of blood clots. Several in vitro and animal studies have indicated that phlorotannins from Ecklonia cava exhibit antithrombotic and anticoagulant properties. For example, studies have shown that these compounds can inhibit platelet aggregation and suppress the activity of clotting factors such as thrombin and factor Xa. One notable study published in "Phytotherapy Research" (2009) found that certain Ecklonia cava phlorotannins significantly prolonged clotting time in animal models. However, it is important to note that clinical trials in humans are lacking, and most of the supportive evidence comes from laboratory or animal experiments.

While the preliminary scientific data is promising and suggests a potential mechanism by which Ecklonia cava may help in the prevention of blood clots, the overall quality and quantity of evidence remain limited. There is no traditional use of Ecklonia cava specifically for blood clot prevention in historical medical systems. Therefore, although there is some scientific basis, its use for this purpose is not yet validated by robust human studies, and caution is advised until further research is conducted.

More about Ecklonia cava
More about Blood Clots (prevention of)

Other ingredients used for Blood Clots (prevention of)

Other health conditions supported by Ecklonia cava

Products containing Ecklonia cava